2020
Systematic review of benzodiazepines for anxiety disorders in late life.
Gupta A, Bhattacharya G, Farheen SA, Funaro M, Balasubramaniam M, Young J, Tampi DJ, Tampi RR. Systematic review of benzodiazepines for anxiety disorders in late life. Annals Of Clinical Psychiatry 2020, 32: 114-127. PMID: 32343283.Peer-Reviewed Educational MaterialsMeSH KeywordsAgedAnxiety DisordersBenzodiazepinesHumansMiddle AgedRandomized Controlled Trials as TopicConceptsAnxiety disordersSystematic reviewOlder adultsTolerability of benzodiazepinesCochrane Central RegisterMild adverse effectsLater lifeEnglish-language articlesTreatment of anxietyLong-term useWeb of ScienceTolerability dataCentral RegisterControlled TrialsCochrane DatabaseOvid EmbaseLong-term benefitsOvid MEDLINEInclusion criteriaEligible articlesBenzodiazepinesDecreased anxietyStudy periodAdverse effectsTrials
2019
Antidepressants for anxiety disorders in late-life: A systematic review.
Balasubramaniam M, Joshi P, Alag P, Gupta S, Maher S, Tampi D, Gupta A, Young J, Tampi RR. Antidepressants for anxiety disorders in late-life: A systematic review. Annals Of Clinical Psychiatry 2019, 31: 277-291. PMID: 31369663.Peer-Reviewed Educational MaterialsMeSH KeywordsAgedAntidepressive AgentsAnxiety DisordersCitalopramDuloxetine HydrochlorideHumansLate Onset DisordersParoxetineRandomized Controlled Trials as TopicSelective Serotonin Reuptake InhibitorsSertralineConceptsLate-life anxietyAnxiety disordersRCTs of antidepressantsCochrane Central RegisterTolerability of antidepressantsBibliographic databases PubMedGeneralized anxiety disorderLong-term useCentral RegisterControlled TrialsAntidepressantsElectronic searchDatabases PubMedSystematic reviewOlder adultsStudy periodTrialsDisordersAnxiety symptomsLater lifeLimited dataSignificant reductionAnxietyReviewTolerability